EntryPoint Capital’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,007	Closed	-$102K	–	903
2024 Q1	$102K	Buy	20,007 +15,760	+371%	+$80.2K	0.09%	408
2023 Q4	$39.5K	Buy	+4,247	New	+$39.5K	0.04%	833